CPT Code Changes for 2015 - South Bend Medical Foundation

TECHNICAL NOTICE
T HE MEDICAL FOU N D ATION
Your Laboratory Experts
A listing of the 2015 changes to Current Procedural Terminology, or CPT, for tests that are offered by The
Medical Foundation appears below. Please update documents and records within your facility to reflect these
changes.
Test No.
Test Description
2015 CPT 4445417-Ketosteroids, Urine 82570; 83586
44973
1p/19q Deletion by FISH 88368; 88369
448795-a-Dihydrotestosterone, Serum 82541
31041Acetaminophen, Serum or Plasma80304
46086Acetaminophen, Urine 80329
46001Acetaminophen, Whole Blood 80329
46077Acetazolamide, Serum or Plasma 80375
35452
Acute Myeloid Leukemia Panel (NPM1 and FLT3), PCR
81245; 81246; 81310
23006Alcohol, Ethyl, Blood80301
23023Alcohol, Ethyl, Urine80301
36176ALK Gene Rearrangement by FISH88374
44485Alprazolam, Serum or Plasma 80346
45501
Amitriptyline and Nortriptyline, Serum or Plasma
80335
29080Amphetamines Screen, Urine80301
44753Amphetamines, Quantitative, Meconium 80326
47155
Amphetamines, Quantitative, Serum or Plasma 80326
47156Amphetamines, Quantitative, Urine 80326
46109Amphetamines, Quantitative, Whole Blood 80326
46017
Antidepressants Panel, Urine 80332; 80337; 80338
47112
Aripiprazole and Metabolite, Serum or Plasma 80342
29081Barbiturates Screen, Urine80301
45449Barbiturates, Quantitative, Meconium80345
44961Barbiturates, Quantitative, Serum or Plasma 80345
47141Barbiturates, Quantitative, Urine 80345
46067Bath Salts Panel, Urine 80371
29082Benzodiazepines Screen, Urine80301
45450Benzodiazepines, Quantitative, Meconium80347
47157
Benzodiazepines, Quantitative, Serum or Plasma 80347
47087Benzodiazepines, Quantitative, Urine 80347
46016Benzodiazepines, Quantitative, Whole Blood 80347
44910
Buprenorphine and Metabolites, Quantitative, Serum or Plasma 80348
47158
Buprenorphine and Metabolites, Quantitative, Urine 80348
44135Bupropion, Serum or Plasma 80338
36365Burkitt Lymphoma Panel by FISH, Tissue88374
44538Butalbital, Serum or Plasma 80345
44757Cannabinoid Metabolite, Quantitative, Meconium80349
44339
Cannabinoid Metabolite, Quantitative, Serum or Plasma 80349
47144Cannabinoid Metabolite, Quantitative, Urine 80349
THE MEDICAL FOUNDATION
5 3 0 N . L afa y ette Bo u le va rd • South B e nd, IN 46601 • (574) 234-4176
E lk h a rt (5 74) 293-8441 • (800) 544-0925
Ro b e rt J . Tome c , M .D . • Me dic al D ire c tor
Test No. Test Description 2015 CPT
46015
Cannabinoids Panel, Quantitative, Whole Blood 80349
29085Cannabinoids Screen, Urine80301
44608
Carisoprodol and Metabolite, Serum or Plasma 80369
46012Carisoprodol and Metabolite, Urine 80369
36338
CCND1/IGH t(11;14) Translocation by FISH, Tissue
88374
47101CEBPA Mutation Detection 81479
44089Chlorpromazine, Serum or Plasma80342
46087Clobazam, Serum or Plasma 80339
46088Clobazam, Urine 80339
46089Clobazam, Whole Blood 80339
44152
Clomipramine and Metabolite, Serum or Plasma 80335
46000Clonazepam and Metabolite, Urine 80346
44018Clonazepam, Serum or Plasma 80346
44963
Clorazepate (Assayed as Nordiazepam), Serum or Plasma 80346
29083Cocaine and Metabolites Screen, Urine80301
44755
Cocaine and Metabolites, Quantitative, Meconium 80353
46110
Cocaine and Metabolites, Quantitative, Whole Blood 80353
47040
Cocaine Metabolite, Quantitative, Serum or Plasma 80353
47142Cocaine Metabolite, Quantitative, Urine 80353
36268
Colorectal Carcinoma Mutation Analysis Panel (BRAF, KRAS, and NRAS)
with Microsatellite Instability Assessment81445
31171Cotinine Screen, Blood80302
31101Cotinine Screen, Urine80302
46100D/L Amphetamines, Urine 80374
45505Desipramine, Serum or Plasma80335
44964
Diazepam and Nordiazepam, Serum or Plasma 80346
46002Diphenhydramine, Serum or Plasma 80375
46003Diphenhydramine, Whole Blood 80375
46098
Diuretics Confirmation, Urine (Reflex Orders Only) 80377
46097
Diuretics Screen with Confirmation if Indicated, Urine 80304
45507Doxepin and Metabolite, Serum or Plasma80335
47182
Drug Detection Panel by High-Resolution Time-of-Flight Mass
Spectrometry, Umbilical Cord Tissue
80301; 80304x2
31232Drug Screen 10, Urine80301
31156
Drug Screen 10, Urine, Alere Triage Meter
80300
31230
Drug Screen 10, with Confirmation/Quantitation if Indicated, Urine 80301
31231
Drug Screen 10, with Creatinine Ratio, Urine
80301; 82570
31164
Drug Screen 11, Urine, Alere Triage Meter
80300
31174
Drug Screen 5, Urine, Alere Triage Meter
80300
29062
Drug Screen 6, Serum
80301; 80302x2
THE MEDICAL FOUNDATION
5 3 0 N . L afa y ette Bo u le v ard • South B e nd, IN 46601 • (574) 234-4176
E lk h a rt (5 74) 293-8441 • (800) 544-0925
R o b ert J . Tome c , M .D . • Me dic al D ire c tor
Test No.
Test Description
2015 CPT
29074Drug Screen 8 plus Alcohol, Urine80301
29072Drug Screen 8, Urine80301
31233
Drug Screen 8, with Confirmation/Quantitation if Indicated, Urine
80301
29068
Drug Screen 8, with Creatinine Ratio, Urine
80301; 82570
29076
Drug Screen 8, with Creatinine Ratio, Urine
(Includes Expanded Opiates/Opioids)80301; 82570
45448
Drug Screen 9, with Confirmation/Quantitation if Indicated, Meconium 80301
44646
Drug Screen 9, with Confirmation/Quantitation if Indicated,
Serum or Plasma 80301
29069
Drug Screen 9, with Creatinine Ratio, Urine
80301; 82570
29077
Drug Screen 9, with Creatinine Ratio, Urine
(Includes Expanded Opiates/Opioids)
80301; 82570
31163
Drug Screen with Volatiles, Blood
80301; 80304x3; 80320
31165
Drug Screen, Comprehensive, Body Fluid
80301; 80304x3
31161
Drug Screen, Comprehensive, Urine
80301; 80304x3
31007
Drug Screen, Gastric Aspirate
80301; 80304x3
31166
Drug Screen, Substance Analysis
80301; 80304x3
46072
Ephedrine, Urine 80324
47178
Ethyl Glucuronide and Ethyl Sulfate Confirmation, Urine
80321
47179
Ethyl Glucuronide Screen with Confirmation if Indicated, Urine
80302
44543Felbamate, Serum or Plasma80339
45853
Fentanyl and Metabolite, Quantitative, Serum or Plasma 80354
47143
Fentanyl and Metabolite, Quantitative, Urine 80354
46025
Fentanyl and Metabolite, Quantitative, Whole Blood 80354
47094FLT3 Mutation Detection, PCR 81245; 81246
46107
Flunitrazepam and Metabolites Confirmation, Urine (Reflex Orders Only) 80346
46103
Flunitrazepam and Metabolites Screen with
Confirmation if Indicated, Urine 80304
44092
Fluoxetine and Metabolite, Serum or Plasma 80332
44090Fluphenazine, Serum or Plasma80342
46033
Gamma-Hydroxybutyric Acid Confirmation,
Serum or Plasma (Reflex Orders Only) 83921
46108
Gamma-Hydroxybutyric Acid Confirmation, Urine (Reflex Orders Only) 83921
46032
Gamma-Hydroxybutyric Acid Screen with Confirmation if Indicated,
Serum or Plasma 80304
46104
Gamma-Hydroxybutyric Acid Screen with
Confirmation if Indicated, Urine 80304
25228
Global Charge - HER2 (ERBB2) Analysis by FISH, Paraffin Block
88374
26106
Global Charge - Immunohistochemistry (including tissue immunoperoxidase),
each additional antibody88341
THE MEDICAL FOUNDATION
5 3 0 N . L afa y ette Bo u le va rd • South B e nd, IN 46601 • (574) 234-4176
E lk h a rt (5 74) 293-8441 • (800) 544-0925
Ro b e rt J . Tome c , M .D . • Me dic al D ire c tor
Test No. Test Description2015 CPT
38553
HER2 (ERBB2) Analysis by FISH, Paraffin Block
88374
43508
Human Papillomavirus (HPV) DNA, High and Low Risk, Anal/Rectal 87624
43507
Human Papillomavirus (HPV) DNA, High Risk, Anal/Rectal 87624
36392
Human Papillomavirus (HPV) DNA, High Risk, Cervical, SurePath®
87624
36391
Human Papillomavirus (HPV) DNA, High Risk, Cervical, ThinPrep®
87624
44593
Human Papillomavirus (HPV) High Risk, in situ Hybridization, Paraffin 88366
44594
Human Papillomavirus (HPV) Low Risk, in situ Hybridization, Paraffin 88366
45618
Human Papillomavirus (HPV) Type-Detect 2.0®, Bio-Plex Analysis,
with HPV-16 Risk Assessment Status if Indicated
87624
46028
Hydrocodone, Free (Unconjugated), Serum or Plasma 80361
47180
Hypoglycemia Panel, Sulfonylureas Qualitative, Serum or Plasma 80377
45708Ibuprofen, Serum or Plasma 80329
36364
IGH/BCL2 t(14;18) Translocation by FISH, Tissue
88374
45504
Imipramine and Desipramine, Serum or Plasma
80335
45924
Inosine Triphosphate (ITPA) and Interleukin 28 B
(IL28B)-Associated Variants, 4 SNPs 81400; 81479
46035
Ketamine and Metabolite Confirmation, Urine (Reflex Orders Only) 80357
46036
Ketamine and Metabolite Screen with Confirmation if Indicated, Urine 80304
45899Lacosamide, Serum or Plasma 80339
46091Levamisole, Serum or Plasma 80375
46092Levamisole, Urine 80375
46093Levamisole, Whole Blood 80375
45997
Librium and Nordiazepam, Serum or Plasma 80346
47181
Liver Fibrosis, Chronic Viral Hepatitis (Echosens FibroMeter) 81599
44541Lorazepam, Serum or Plasma 80346
43503LSD (Lysergic Acid Diethylamide), Urine 80323
46039
MDPV Stimulant Designer Drug Test, Urine 80371
36270
Melanoma Mutation Analysis Panel (BRAF, KIT, and NRAS)
81445
44912
Meperidine and Metabolite, Quantitative, Serum or Plasma 80362
47145
Meperidine and Metabolite, Quantitative, Urine 80362
44437Mephobarbital, Serum or Plasma 80345
44962Meprobamate, Serum or Plasma 80369
45451
Methadone and Metabolite, Quantitative, Meconium
80358
44347
Methadone and Metabolite, Quantitative, Serum or Plasma 80358
47146
Methadone and Metabolite, Quantitative, Urine 80358
46111
Methadone and Metabolite, Quantitative, Whole Blood 80358
31258Methadone Screen, Urine80301
46105Methaqualone, Urine 80368
44146
Methsuximide and Normethsuximide, Serum or Plasma 80339
44353
Methylphenidate and Metabolite, Serum or Plasma 80360
THE MEDICAL FOUNDATION
5 3 0 N . L afa y ette Bo u le v ard • South B e nd, IN 46601 • (574) 234-4176
E lk h a rt (5 74) 293-8441 • (800) 544-0925
R o b ert J . Tome c , M .D . • Me dic al D ire c tor
Test No.
Test Description
2015 CPT
45734Methylphenidate and Metabolite, Urine 80360
38520
Mismatch Repair (MMR) Analysis by
Immunohistochemistry (IHC)
88342; 88341x3
45890Mitochondrial Disorders (mtDNA) Sequencing 81460
45891
Mitochondrial Disorders Panel (mtDNA and 108 Nuclear Genes)
Sequencing and Deletion/Duplication 81404x12; 81405x25; 81406x19; 81407; 81460; 81465; 81479
45888
Mitochondrial Genome (mtDNA and 108 Nuclear Genes)
Deletion/Duplication 81404x3; 81405x2; 81406; 81465; 81479
47186
MLH1 Promoter Methylation, Paraffin 81288; 88381
45595
Mucopolysaccharides Screen - Electrophoresis and Quantitation, Urine
82664; 83864
46046Naproxen, Urine 80329
44552
Nicotine and Metabolites, Quantitative, Serum or Plasma 80323
44352
Nicotine and Metabolites, Quantitative, Urine 80323
36269
Non-Small Cell Lung Carcinoma Mutation Analysis Panel (BRAF, EGFR,
and KRAS) with ALK, RET, and ROS1 by FISH if Indicated
81445
36299
Non-Small Cell Lung Carcinoma Panel by FISH
88374x3
45502Nortriptyline, Serum or Plasma80335
44019Olanzapine, Serum or Plasma 80342
29084Opiates Screen, Urine80301
44756
Opiates, Quantitative, Meconium
80356; 80361; 80365
47041
Opiates, Quantitative, Serum or Plasma 80356; 80361; 80365
47017
Opiates, Quantitative, Urine 80356; 80361; 80365
46112
Opiates, Quantitative, Whole Blood 80356; 80361; 80365
31234
Opiates/Opioids Screen, with Confirmation/Quantitation
if Indicated, Urine 80301
47150
Pain Management Drug Panel with Interpretation,
LC-TOF/MS and EIA, Urine 80301; 80302x3; 80304
47149
Pain Management Drug Panel, LC-TOF/MS and EIA, Urine
80301; 80302x3; 80304
31472
Pain Management Panel A (14 Drugs), Urine
80301; 80302x3
31473
Pain Management Panel A (14 Drugs),
with Confirmation/Quantitation if Indicated, Urine
80301; 80302x3
31474
Pain Management Panel B (10 Drugs), Urine
80301; 80302x3
31475
Pain Management Panel B (10 Drugs),
with Confirmation/Quantitation if Indicated, Urine
80301; 80302x3
45751
PCA3 - Prostate Cancer Biomarker by Transcription-Mediated Amplification 81313
31077Pentobarbital, Serum80345
29086Phencyclidine (PCP) Screen, Urine80301
37365
Professional Component Charge - HER2 (ERBB2)
Analysis by FISH, Paraffin Block
88374-26
37020
Professional Component Charge - Immunohistochemistry
(including tissue immunoperoxidase), each additional antibody
88341-26
THE MEDICAL FOUNDATION
5 3 0 N . L afa y ette Bo u le v ard • South B e nd, IN 46601 • (574) 234-4176
E lk h a rt (5 74) 293-8441 • (800) 544-0925
R o b ert J . Tome c , M .D . • Me dic al D ire c tor
Test No.
Test Description
2015 CPT
45452
Propoxyphene and Metabolite, Quantitative, Meconium
80367
47169
Propoxyphene and Metabolite, Quantitative, Serum or Plasma
80367
47170Propoxyphene and Metabolite, Quantitative, Urine80367
29087Propoxyphene Screen, Urine80301
44870Protriptyline, Serum or Plasma 80335
45104Quetiapine, Serum or Plasma 80342
46084Ranitidine, Urine 80375
36278RET Gene Rearrangement by FISH88374
44157
Risperidone and Metabolite, Serum or Plasma
80342
36277ROS1 Gene Rearrangement by FISH88374
45894Rufinamide, Serum or Plasma 80339
29151Salicylate, Serum80302
46090Salicylate, Whole Blood 80329
44570Sertraline, Serum or Plasma 80332
29091SJRMC Serum Drug Sceern CLAB80301
29090
SJRMC Serum Drug Screen Onsite
80301; 80302x2
36271
Solid Tumor Mutation Analysis Panel (BRAF, EGFR, KIT, KRAS, and NRAS)
81445
45630Sulfonylurea Screen, Urine 80377
46059
Synthetic Cannabinoid Metabolites Confirmation (Qualitative),
Urine (Reflex Orders Only) 80352
46058
Synthetic Cannabinoid Metabolites Screen with
Confirmation if Indicated, Urine
80302x2
45812
Tapentadol and Metabolite, Quantitative, Serum or Plasma 80372
45811
Tapentadol and Metabolite, Quantitative, Urine 80372
26365
Technical Component Charge - HER2 (ERBB2)
Analysis by FISH, Paraffin Block 88374-TC
26343
Technical Component Charge - Immunohistochemistry (including tissue
immunoperoxidase), each additional antibody
88341-TC
44639Thiothixene, Serum or Plasma 80342
44914
Tramadol and Metabolites, Quantitative, Serum or Plasma 80373
44915
Tramadol and Metabolites, Quantitative, Urine 80373
44058Trazodone, Serum or Plasma 80338
46061Trazodone, Urine 80338
47073
Tricyclic Antidepressants Panel, Quantitative, Serum or Plasma 80337
29140Tricyclic Antidepressants, Qualitative, Serum80301
29075Valproic Acid, Free80165
29160Vanillylmandelic Acid, Urine, 24-Hour84585
45193
Venlafaxine and Metabolite, Serum or Plasma 80338
31035Volatiles, Blood80320
45111Ziprasidone, Serum or Plasma80342
THE MEDICAL FOUNDATION
5 3 0 N . L afa y ette Bo u le va rd • South B e nd, IN 46601 • (574) 234-4176
E lk h a rt (5 74) 293-8441 • (800) 544-0925
Ro b e rt J . Tome c , M .D . • Me dic al D ire c tor